Syneos Health, Inc.
SYNHNASDAQHealthcare
$42.98
+$0.01(+0.02%)
Market Cap$4.5B
P/E Ratio—
52W High$52.23
52W Low$22.894
Syneos Health, Inc. (SYNH) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
SYNH · earnings · updated Jun 8, 2026
Latest Earnings
Q4 FY2023Report Date: Nov 2, 2023EPS Actual
$1.13
Est. $0.81 · +39.5%
Revenue
—
Est. $1.25B
Fiscal Period
Q4 FY2023
FY ends December
Report Date
Nov 2, 2023
After Market Close
▲ Beat EPS✓ 1-Quarter EPS Beat Streak
SYNH reports quarterly as a NASDAQ-listed Medical - Diagnostics & Research company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2024 | Aug 7, 2024 | — | — | — | — | — | — |
| ◌ Q2 FY2024 | May 8, 2024 | — | — | — | — | — | — |
| ◌ Q1 FY2024 | Feb 14, 2024 | — | — | — | — | — | — |
| ▲ Q4 FY2023 | Nov 2, 2023 | $0.81 | $1.13 | +39.5% | — | $1.25B | — |
| ▼ Q3 FY2023 | Aug 8, 2023 | $0.78 | $0.01 | -98.7% | $1.37B | $1.27B | +7.4% |
| ▲ Q2 FY2023 | May 10, 2023 | $0.67 | $0.75 | +11.9% | $1.36B | $1.28B | +5.9% |
| ▲ Q1 FY2023 | Feb 16, 2023 | $1.18 | $1.23 | +4.2% | $1.36B | $1.29B | +5.3% |
| ▼ Q4 FY2022 | Nov 3, 2022 | $1.32 | $1.23 | -6.8% | $1.34B | — | — |
Q3 FY2024
Aug 7, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2024
May 8, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2024
Feb 14, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2023
Nov 2, 2023Beat
EPS Actual
$1.13
EPS Est.
$0.81
EPS Surpr.
+39.5%
Revenue
—
Q3 FY2023
Aug 8, 2023Miss
EPS Actual
$0.01
EPS Est.
$0.78
EPS Surpr.
-98.7%
Revenue
$1.37B
Q2 FY2023
May 10, 2023Beat
EPS Actual
$0.75
EPS Est.
$0.67
EPS Surpr.
+11.9%
Revenue
$1.36B
Q1 FY2023
Feb 16, 2023Beat
EPS Actual
$1.23
EPS Est.
$1.18
EPS Surpr.
+4.2%
Revenue
$1.36B
Q4 FY2022
Nov 3, 2022Miss
EPS Actual
$1.23
EPS Est.
$1.32
EPS Surpr.
-6.8%
Revenue
$1.34B
No analyst estimates available for SYNH.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q4 FY2023 | Nov 2, 2023 | +39.5% | $42.98 | — | — |
| ▼ Q3 FY2023 | Aug 8, 2023 | -98.7% | $42.47 | $42.56 | +0.21% |
| ▲ Q2 FY2023 | May 10, 2023 | +11.9% | $38.45 | $41.85 | +8.84% |
| ▲ Q1 FY2023 | Feb 16, 2023 | +4.2% | $35.92 | $39.22 | +9.19% |
| ▼ Q4 FY2022 | Nov 3, 2022 | -6.8% | $49.02 | $47.81 | -2.47% |
| ▲ Q3 FY2022 | Aug 2, 2022 | +4.2% | $79.14 | $65.20 | -17.61% |
| ▲ Q2 FY2022 | Apr 29, 2022 | +5.2% | $70.46 | $73.09 | +3.73% |
| ▲ Q1 FY2022 | Feb 17, 2022 | +3.5% | $83.37 | $79.36 | -4.81% |
Q4 FY2023—
Report Date
Nov 2, 2023
EPS Beat/Miss
+39.5%
Price Before
$42.98
Price After
—
Q3 FY2023+0.21%
Report Date
Aug 8, 2023
EPS Beat/Miss
-98.7%
Price Before
$42.47
Price After
$42.56
Q2 FY2023+8.84%
Report Date
May 10, 2023
EPS Beat/Miss
+11.9%
Price Before
$38.45
Price After
$41.85
Q1 FY2023+9.19%
Report Date
Feb 16, 2023
EPS Beat/Miss
+4.2%
Price Before
$35.92
Price After
$39.22
Q4 FY2022-2.47%
Report Date
Nov 3, 2022
EPS Beat/Miss
-6.8%
Price Before
$49.02
Price After
$47.81
Q3 FY2022-17.61%
Report Date
Aug 2, 2022
EPS Beat/Miss
+4.2%
Price Before
$79.14
Price After
$65.20
Q2 FY2022+3.73%
Report Date
Apr 29, 2022
EPS Beat/Miss
+5.2%
Price Before
$70.46
Price After
$73.09
Q1 FY2022-4.81%
Report Date
Feb 17, 2022
EPS Beat/Miss
+3.5%
Price Before
$83.37
Price After
$79.36
Avg Beat Reaction-0.13%
Avg Miss Reaction-1.13%
Beat Rate6 / 8 quarters
Largest Move-17.61% (Q3 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: SYNH ends December
Syneos Health, Inc. (SYNH) most recently reported earnings on November 2, 2023 for Q4 FY2023, posting EPS of $1.13 — beating the analyst consensus of $0.81 by +39.5%. The next SYNH earnings date is expected around September 1, 2026.
Each quarter, investors track SYNH earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. SYNH revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
SYNH's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
SYNH earnings · 5 questionsSyneos Health, Inc.'s next earnings report is expected around September 1, 2026. SYNH typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; SYNH historically reports after market close (AMC).
SYNH earnings datewhen is SYNH earningsSYNH next earnings datewhen does SYNH report earningsSYNH earnings calendar
▸ Source: FMP · Syneos Health, Inc. SEC filings · US GAAP · Syneos Health, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026